Omada Health, Inc.
OMDA
$18.32
$0.442.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 49.36% | 53.24% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.36% | 53.24% | -- | -- | -- |
| Cost of Revenue | 32.29% | 33.39% | -- | -- | -- |
| Gross Profit | 59.87% | 66.16% | -- | -- | -- |
| SG&A Expenses | 31.01% | 28.59% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.36% | 27.51% | -- | -- | -- |
| Operating Income | 75.46% | 72.58% | -- | -- | -- |
| Income Before Tax | 83.25% | 72.89% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 83.25% | 72.89% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 83.25% | 72.89% | -- | -- | -- |
| EBIT | 75.46% | 72.58% | -- | -- | -- |
| EBITDA | 90.74% | 83.32% | -- | -- | -- |
| EPS Basic | 94.58% | 77.98% | -- | -- | -- |
| Normalized Basic EPS | 95.34% | 78.58% | -- | -- | -- |
| EPS Diluted | 94.41% | 77.85% | -- | -- | -- |
| Normalized Diluted EPS | 95.17% | 78.44% | -- | -- | -- |
| Average Basic Shares Outstanding | 521.59% | 372.53% | -- | -- | -- |
| Average Diluted Shares Outstanding | 540.16% | 391.55% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |